Developer docs
API playgroundTry for free, no card

Search company profiles

Matrix Partners China

Full company profile

uuid00002px

Namestring
Matrix Partners China
Legal namestring
Matrix Partners China (Beijing) Investment Management Consulting Co., Ltd. [经纬创投(北京)投资管理顾问有限公司]
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Matrix Partners China (MPCi / 经纬创投) is a Beijing-headquartered venture capital firm founded in 2008 that invests in early-stage and early-growth Chinese startups, with offices in Beijing and Shanghai. The firm is privately held under the legal entity Matrix Partners China (Beijing) Investment Management Consulting Co., Ltd. [经纬创投(北京)投资管理顾问有限公司] and reports assets under management of over 70 billion RMB across multiple RMB-denominated funds, with cumulative investment in more than 800 portfolio companies. Sector coverage spans new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands.

The firm runs two core offerings. The first is the primary venture capital investment service, under which MPCi originates and leads or co-leads equity rounds — preferring to be the first institutional investor and largest non-management shareholder, with multi-round follow-on participation through the company lifecycle. Recent disclosed deals include the Jieyue Xingchen RMB 5 billion Series B+ (February 2026), Digua Robotics $120M Series B1 (March 2026), Aureka Biotechnologies $35M Series A+ (April 2026), AeroBand's RMB ~100M Series A (March 2026), Aikou Lian Biotechnology's $27.7M A+ round (March 2026), and the RoboParty seed co-led with Xiaomi (November 2025). The second is a portfolio management service — one of the largest in the Chinese VC market — with over 80 professionals organized across 10 functions including strategy and operations consulting, recruiting, and healthcare services, providing value-added post-investment support to founders.

Revenue mechanics follow the standard Chinese VC model: management fees on committed/invested capital across multiple RMB funds, plus carried interest on exits (IPO, M&A, secondary sales) from the 800+ portfolio companies. Distribution is direct — founders engage MPCi through its Beijing and Shanghai offices, its bilingual website, its WeChat public account (经纬创投) and Weibo account (经纬创投官方微博), and ecosystem events such as the AI Future Forum at Zhongguancun (March 2026). Marketing is brand-led, reinforced by consistent top-tier placements in independent 2025-2026 Chinese VC rankings (36Kr TOP5, Zero2IPO TOP10, Jiemian News TOP5, Cyzone Most Admired VC TOP5, Beijing PE/VC TOP20, TMTpost Pioneer lists).

Short descriptiontext

Matrix Partners China (MPCi) is a Beijing-headquartered, early-stage and early-growth venture capital firm founded in 2008, managing over 70 billion RMB and investing across 800+ Chinese startups in new economy, deep tech, healthcare, frontier technology, and consumer brands, with an 80-person portfolio management team.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage equity funding, growth-stage venture capital, portfolio management services, Chinese startup financing
Industry2 codes
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
2Technology & Software Growth Equity
CodeFSANACAAPrimaryNo
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Private Equity
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management & Capital Deployment
TypeManaged Services
Description

Revenue model typical of a Chinese venture capital firm: earns management fees on the more than 70 billion RMB in assets under management from multiple RMB-denominated funds, deployed across early-stage and early-growth equity investments in Chinese startups. Capital is invested into portfolio companies with the goal of follow-on participation through a company's life cycle.

matrixpartners.com.cn
2Investment Gains & Value-added Services
TypeTransaction Fee
Description

Earns carried interest / investment returns from exits (IPO, M&A, secondary sales) of more than 800 portfolio companies, plus incremental value from over 80 professionals providing post-investment services across 10 functions (strategy, operations, talent recruiting, healthcare services, etc.) that strengthen portfolio outcomes.

matrixpartners.com.cn
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Matrix Partners China invests early-stage and early-growth equity capital into Chinese startups across new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands, managing over 70 billion RMB in AUM across 800+ portfolio companies. The firm supplements its capital with an 80+ person in-house portfolio management team organized across 10 functions (strategy, operations consulting, recruiting, healthcare services) that delivers post-investment value-added services to portfolio founders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 70 billion RMB AUM and 800+ portfolio companies since 2008
+2 more records
Product overview1 text field

Matrix Partners China (MPCi / 经纬创投) operates as a single unified venture capital firm rather than a platform-plus-modules product architecture. Its core offering is early-stage and early-growth equity investment in Chinese companies, complemented by a large in-house portfolio management team. MPCi invests across new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands, while its Portfolio Management Services provide post-investment support in strategy, operations, recruiting, and healthcare across its 800+ portfolio companies.

Product and service2 records
1Matrix Partners China (MPCi) Venture Capital Investment Services
CategoryVenture Capital Investment
Description

Core equity investment service of Matrix Partners China: deploying early-stage and early-growth venture capital from over 70 billion RMB in assets under management into Chinese startups across six sector verticals, with the firm preferring to act as the first institutional investor and largest non-management shareholder and providing follow-on capital across the company lifecycle.

2Matrix Partners China Portfolio Management Services
CategoryPortfolio Management / Value-Added Services
Description

Post-investment value-added service offering run by an 80+ person in-house portfolio management team organized into 10 functions (strategy and operations consulting, recruiting, healthcare services, among others), delivered to Matrix Partners China's 800+ portfolio companies to strengthen operational and commercial outcomes alongside the firm's capital.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026. Ecosystem partnership involves Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, GSR Ventures, and Zhenzhi Capital.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Matrix Partners China, GGV Capital, GSR Ventures, and Zhenzhi Capital.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GSR Ventures, and Zhenzhi Capital.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, and Zhenzhi Capital.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, and GSR Ventures.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GGV Capital is a global venture firm with significant China presence investing in early- and growth-stage enterprise, consumer, and frontier-tech companies. It co-signed the AI Future Forum ecosystem partnership with Matrix Partners China and competes in overlapping sectors.

TypeDirect peer
Description

Source Code Capital is a leading early-stage China VC focused on internet, enterprise software, fintech, and deep tech, with comparable AUM scale and a similar founder-first, first-in investing model. It is a direct peer in the early-stage segment of Matrix Partners China's portfolio.

TypeDirect peer
Description

Qiming is a leading early-stage China VC investing in internet, consumer, healthcare, and deep tech. It is a co-investor with Matrix Partners China (e.g., Jieyue Xingchen, Aureka Bio) and competes head-to-head in Series A and B rounds across the same sectors.

TypeEmerging player
Description

ZhenFund is a China-focused seed-stage venture fund with a large portfolio of consumer and internet startups. It is a partial peer focused on the earliest stages of Matrix Partners China's target founder pool, particularly in new consumer and internet sectors.

TypeDirect peer
Description

HongShan is the leading China-focused venture capital firm spun out of Sequoia Capital in 2023, with comparable AUM scale and a similar early-stage and growth investment focus across new economy, deep tech, healthcare, and consumer. It is Matrix Partners China's closest direct competitor in deal sourcing, talent, and brand.

TypeDirect peer
Description

Hillhouse is a top-tier China-focused investment firm with deep exposure to consumer, healthcare, and business services across venture, growth, and public markets. It is a frequent co-investor and direct competitor to Matrix Partners China on large Chinese growth rounds.

TypeDirect peer
Description

IDG Capital is one of the earliest entrants into China VC with broad early-stage coverage across TMT, consumer, healthcare, and advanced manufacturing. It competes with Matrix Partners China for the same early-stage founder pool and Tier-1 brand positioning.

TypeDirect peer
Description

Shunwei Capital is the venture arm of Xiaomi founder Lei Jun, focused on internet, deep tech, IoT, and consumer. It co-led Matrix Partners China's seed investment in RoboParty and competes for the same deep-tech and hardware-adjacent early-stage deals in China.

TypeRegional player
Description

DCM is a global venture firm with active presence in China and the US, focused on early-stage enterprise, consumer, and fintech investments. It is comparable to Matrix Partners China on cross-border and US-China venture investing, though its China footprint is smaller.

TypeDirect peer
Description

GSR Ventures is a China-focused early-stage VC with deep digital, AI, and enterprise software coverage. It co-signed the Zhongguancun AI Future Forum ecosystem partnership with Matrix Partners China and is a direct peer in early-stage Chinese tech deals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment841 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Matrix Partners China

Venture Capital / Private Equitymatrixpartners.com.cn

Matrix Partners China (MPCi) is a Beijing-headquartered, early-stage and early-growth venture capital firm founded in 2008, managing over 70 billion RMB and investing across 800+ Chinese startups in new economy, deep tech, healthcare, frontier technology, and consumer brands, with an 80-person portfolio management team.

What Matrix Partners China does

Matrix Partners China (MPCi / 经纬创投) is a Beijing-headquartered venture capital firm founded in 2008 that invests in early-stage and early-growth Chinese startups, with offices in Beijing and Shanghai. The firm is privately held under the legal entity Matrix Partners China (Beijing) Investment Management Consulting Co., Ltd. [经纬创投(北京)投资管理顾问有限公司] and reports assets under management of over 70 billion RMB across multiple RMB-denominated funds, with cumulative investment in more than 800 portfolio companies. Sector coverage spans new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands.

The firm runs two core offerings. The first is the primary venture capital investment service, under which MPCi originates and leads or co-leads equity rounds — preferring to be the first institutional investor and largest non-management shareholder, with multi-round follow-on participation through the company lifecycle. Recent disclosed deals include the Jieyue Xingchen RMB 5 billion Series B+ (February 2026), Digua Robotics $120M Series B1 (March 2026), Aureka Biotechnologies $35M Series A+ (April 2026), AeroBand's RMB ~100M Series A (March 2026), Aikou Lian Biotechnology's $27.7M A+ round (March 2026), and the RoboParty seed co-led with Xiaomi (November 2025). The second is a portfolio management service — one of the largest in the Chinese VC market — with over 80 professionals organized across 10 functions including strategy and operations consulting, recruiting, and healthcare services, providing value-added post-investment support to founders.

Revenue mechanics follow the standard Chinese VC model: management fees on committed/invested capital across multiple RMB funds, plus carried interest on exits (IPO, M&A, secondary sales) from the 800+ portfolio companies. Distribution is direct — founders engage MPCi through its Beijing and Shanghai offices, its bilingual website, its WeChat public account (经纬创投) and Weibo account (经纬创投官方微博), and ecosystem events such as the AI Future Forum at Zhongguancun (March 2026). Marketing is brand-led, reinforced by consistent top-tier placements in independent 2025-2026 Chinese VC rankings (36Kr TOP5, Zero2IPO TOP10, Jiemian News TOP5, Cyzone Most Admired VC TOP5, Beijing PE/VC TOP20, TMTpost Pioneer lists).

Matrix Partners China firmographics

Firmographics
Name
Matrix Partners China
Legal name
Matrix Partners China (Beijing) Investment Management Consulting Co., Ltd. [经纬创投(北京)投资管理顾问有限公司]
Website
https://matrixpartners.com.cn
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Matrix Partners China (MPCi) is a Beijing-headquartered, early-stage and early-growth venture capital firm founded in 2008, managing over 70 billion RMB and investing across 800+ Chinese startups in new economy, deep tech, healthcare, frontier technology, and consumer brands, with an 80-person portfolio management team.
Ownership category
akta.pro rank

Matrix Partners China industry classification

Industry
Product category
Venture Capital / Private Equity
NAICS
Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
akta.pro secondary industry
Technology & Software Growth Equity (FSANACAA)

Keywords

  • Venture capital investing
  • Early-stage equity funding
  • Growth-stage venture capital
  • Portfolio management services
  • Chinese startup financing

Where Matrix Partners China is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices2 records

Markets served

Matrix Partners China business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Fund Management & Capital Deployment: Revenue model typical of a Chinese venture capital firm: earns management fees on the more than 70 billion RMB in assets under management from multiple RMB-denominated funds, deployed across early-stage and early-growth equity investments in Chinese startups. Capital is invested into portfolio companies with the goal of follow-on participation through a company's life cycle.
  2. Investment Gains & Value-added Services: Earns carried interest / investment returns from exits (IPO, M&A, secondary sales) of more than 800 portfolio companies, plus incremental value from over 80 professionals providing post-investment services across 10 functions (strategy, operations, talent recruiting, healthcare services, etc.) that strengthen portfolio outcomes.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Matrix Partners China product offering

Product offering

Core offering

Matrix Partners China invests early-stage and early-growth equity capital into Chinese startups across new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands, managing over 70 billion RMB in AUM across 800+ portfolio companies. The firm supplements its capital with an 80+ person in-house portfolio management team organized across 10 functions (strategy, operations consulting, recruiting, healthcare services) that delivers post-investment value-added services to portfolio founders.

Product overview

Matrix Partners China (MPCi / 经纬创投) operates as a single unified venture capital firm rather than a platform-plus-modules product architecture. Its core offering is early-stage and early-growth equity investment in Chinese companies, complemented by a large in-house portfolio management team. MPCi invests across new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands, while its Portfolio Management Services provide post-investment support in strategy, operations, recruiting, and healthcare across its 800+ portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Matrix Partners China (MPCi) Venture Capital Investment Services Core equity investment service of Matrix Partners China: deploying early-stage and early-growth venture capital from over 70 billion RMB in assets under management into Chinese startups across six sector verticals, with the firm preferring to act as the first institutional investor and largest non-management shareholder and providing follow-on capital across the company lifecycle.
  • Matrix Partners China Portfolio Management Services Post-investment value-added service offering run by an 80+ person in-house portfolio management team organized into 10 functions (strategy and operations consulting, recruiting, healthcare services, among others), delivered to Matrix Partners China's 800+ portfolio companies to strengthen operational and commercial outcomes alongside the firm's capital.

Quantifiable outcome

  • Over 70 billion RMB AUM and 800+ portfolio companies since 2008
  • +2 more outcomes

Companies that use Matrix Partners China

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Matrix Partners China technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Matrix Partners China partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship.

  • Sequoia ChinaflagshipStrategic or Co-development Partner · 29 March 2026Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026. Ecosystem partnership involves Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, GSR Ventures, and Zhenzhi Capital.
  • Hillhouse CapitalflagshipStrategic or Co-development Partner · 29 March 2026Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Matrix Partners China, GGV Capital, GSR Ventures, and Zhenzhi Capital.
  • GGV CapitalflagshipStrategic or Co-development Partner · 29 March 2026Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GSR Ventures, and Zhenzhi Capital.
  • GSR VenturesflagshipStrategic or Co-development Partner · 29 March 2026Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, and Zhenzhi Capital.
  • Zhenzhi CapitalflagshipStrategic or Co-development Partner · 29 March 2026Co-signed as ecosystem partner for the International Innovation Service Aggrarian Area during the AI Future Forum at the Zhongguancun International Innovation Center, Haidian District, Beijing, on March 29, 2026, alongside Sequoia China, Hillhouse Capital, Matrix Partners China, GGV Capital, and GSR Ventures.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Matrix Partners China competitors and assessment

Company assessment

Direct peers

  • GGV Capital: GGV Capital is a global venture firm with significant China presence investing in early- and growth-stage enterprise, consumer, and frontier-tech companies. It co-signed the AI Future Forum ecosystem partnership with Matrix Partners China and competes in overlapping sectors.
  • Source Code Capital: Source Code Capital is a leading early-stage China VC focused on internet, enterprise software, fintech, and deep tech, with comparable AUM scale and a similar founder-first, first-in investing model. It is a direct peer in the early-stage segment of Matrix Partners China's portfolio.
  • Qiming Venture Partners: Qiming is a leading early-stage China VC investing in internet, consumer, healthcare, and deep tech. It is a co-investor with Matrix Partners China (e.g., Jieyue Xingchen, Aureka Bio) and competes head-to-head in Series A and B rounds across the same sectors.
  • HongShan (formerly Sequoia China): HongShan is the leading China-focused venture capital firm spun out of Sequoia Capital in 2023, with comparable AUM scale and a similar early-stage and growth investment focus across new economy, deep tech, healthcare, and consumer. It is Matrix Partners China's closest direct competitor in deal sourcing, talent, and brand.
  • Hillhouse Capital: Hillhouse is a top-tier China-focused investment firm with deep exposure to consumer, healthcare, and business services across venture, growth, and public markets. It is a frequent co-investor and direct competitor to Matrix Partners China on large Chinese growth rounds.
  • IDG Capital: IDG Capital is one of the earliest entrants into China VC with broad early-stage coverage across TMT, consumer, healthcare, and advanced manufacturing. It competes with Matrix Partners China for the same early-stage founder pool and Tier-1 brand positioning.
  • Shunwei Capital: Shunwei Capital is the venture arm of Xiaomi founder Lei Jun, focused on internet, deep tech, IoT, and consumer. It co-led Matrix Partners China's seed investment in RoboParty and competes for the same deep-tech and hardware-adjacent early-stage deals in China.
  • GSR Ventures: GSR Ventures is a China-focused early-stage VC with deep digital, AI, and enterprise software coverage. It co-signed the Zhongguancun AI Future Forum ecosystem partnership with Matrix Partners China and is a direct peer in early-stage Chinese tech deals.

Emerging players

  • ZhenFund: ZhenFund is a China-focused seed-stage venture fund with a large portfolio of consumer and internet startups. It is a partial peer focused on the earliest stages of Matrix Partners China's target founder pool, particularly in new consumer and internet sectors.

Regional players

  • DCM (Doll Capital Management): DCM is a global venture firm with active presence in China and the US, focused on early-stage enterprise, consumer, and fintech investments. It is comparable to Matrix Partners China on cross-border and US-China venture investing, though its China footprint is smaller.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Matrix Partners China social profiles

Digital presence

Matrix Partners China financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Matrix Partners China leadership team

Management profile

Number of profiles

Profiles10 records

Matrix Partners China funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Matrix Partners China M&A and investment

M&A and investment

M&A

Investments841 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Matrix Partners China

What does Matrix Partners China do?

Matrix Partners China invests early-stage and early-growth equity capital into Chinese startups across new economy, deep technology, industrial digitalization, healthcare, frontier technology, and new consumer brands, managing over 70 billion RMB in AUM across 800+ portfolio companies. The firm supplements its capital with an 80+ person in-house portfolio management team organized across 10 functions (strategy, operations consulting, recruiting, healthcare services) that delivers post-investment value-added services to portfolio founders.

Is Matrix Partners China a public or private company?

Matrix Partners China is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Matrix Partners China founded?

Matrix Partners China was founded in 2008. It employs 11 to 50 people.

Where is Matrix Partners China based?

Matrix Partners China is headquartered in Beijing, China, in the Asia region.

How does Matrix Partners China make money?

Two revenue lines are on record. Fund Management & Capital Deployment is the primary driver. The others are investment Gains & Value-added Services.

Who are Matrix Partners China's main competitors?

Direct peers on record are GGV Capital, Source Code Capital, Qiming Venture Partners, HongShan (formerly Sequoia China), Hillhouse Capital, IDG Capital, Shunwei Capital and GSR Ventures. ZhenFund is listed as an emerging player. DCM (Doll Capital Management) is listed as a regional player.

Does Matrix Partners China have an API?

No public API is recorded for Matrix Partners China.

What industry is Matrix Partners China in?

Matrix Partners China's product category is Venture Capital / Private Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChinaventureFirst release | Incubated by the Institute of Semiconductors, Chinese Academy of Sciences, post-90s PhD Xiao Ye has raised nearly 100 million yuan again.Ising Intelligence, a company developing optoelectronic Ising machines for combinatorial optimization, raised nearly 100 million yuan in financing led by Shunxi Angel Fund. The team's machines have achieved over 4,000 spins with stable operation, and they plan to launch a product with tens of thousands of spins in December.36krGalaxy General: 34 Months Post-Establishment, 6 Rounds of Financing Totaling 7 Billion Yuan – Confidence & Hidden Worries of the "Capital Harvester" on the Embodied Intelligence TrackGalaxy Universal, founded by Wang He in May 2023, has raised about 70 billion RMB in six financing rounds over 34 months, with a valuation exceeding 200 billion RMB. The company's AstraBrain large model and robots like Galbot S1 and G1 have been deployed in industrial and commercial scenarios. The article notes concerns about commercialization and state-owned capital's influence.Fastdata极数苏州自动化柔性化技术及解决方案研发商纵苇科技获得2亿人民币Pre-C++轮融资 – Fastdata极数Zongwei Technology, a Suzhou automation flexible technology developer, raised 200 million RMB in Pre-C++ financing led by Jingwei Venture Capital. The funds will support R&D of core products like intelligent magnetic drive control platforms and planar magnetic levitation, as well as capacity expansion and globalization.Jixin君联资本等看好,这家中国 Biotech 拿下 5.4 亿元融资NeuShen Therapeutics completed over 80 million USD (about 540 million yuan) in oversubscribed Series B financing on September 3, led by industry capital including Junlian Capital. The company, focused on CNS small molecules, has three core projects in clinical development, including NS-079 for depression and NS-136 for schizophrenia and Alzheimer's.Fastdata极数Shanghai-based central nervous system innovative drug developer Neurona Therapeutics completes over $80 million Series B financing – FastdataNuooshen Pharmaceutical completed over $80 million in Series B financing, led by industry capital with participation from B Capital, Junlian Capital, and others. Existing shareholder Eli Lilly Asia Fund increased its investment.36kr"Tiangong Robotics" has secured hundreds of millions of yuan in financing.-36氪Tiangong Robotics completed a financing round of several hundred million yuan led by Chu Xin Fund, with follow-on investments from Matrix Partners China and Hefei State-owned Capital Investment. The funds will be used to expand mass production of sorting robots, develop humanoid-based sorting robots, and expand overseas business.36krVAST has completed its Series B and Series B+ financing-36氪VAST completed its Series B and Series B+ financing rounds, raising about 3 billion yuan total. The round was led by Matrix Partners China, with industrial and financial investors participating. The company has now raised about 5 billion yuan in accumulated financing, setting a new record for the AI 3D field.JixinVAST raised about 5 billion in financing over the past six months: once a non-consensus player, now it has become the 'foundation of the world' | Intelligent Emergence First ReleaseVAST raised about 5 billion yuan in Series B and B+ financing over six months, led by Matrix Partners. The company's Tripo P2.0 model generates quadrilateral meshes in seconds, and its Tripo Studio has served tens of millions of users. VAST plans to expand AI 3D into world-building with Project Eden.ChinaventureVAST完成约30亿元B和B+轮融资VAST completed Series B and B+ financing totaling approximately 3 billion RMB, led by Matrix Partners. Existing shareholders exceeded their follow-on investments, and Huaxing Capital served as exclusive financial advisor.Fastdata极数TianGong Robotics, a service provider of intelligent sorting solutions in the logistics and warehousing sector in Beijing, announced the completion of financing worth hundreds of millions.Tiangong Robotics, a Beijing-based intelligent sorting solutions provider, completed financing worth hundreds of millions of yuan. The round was led by Chuxin Fund, with follow-on investments from Jingwei Venture Capital, Hefei State-owned Assets, and other institutions.